🌐 Live from the web
Updated 9/17/2026Market news
The breakthroughs, deals and approvals moving the bio-economy — tracked across every sector, updated daily.
All sectors🧬 Biotech🍽️ Food-tech🌱 Agri-tech🦠 Probiotics💊 Personalized Medicine⚗️ Bioprocessing📈 Biotech Investment🔬 Research & Academia🏛️ Policy & Strategy🤖 AI in Biotech
📈 Biotech InvestmentSep 16, 2026
Arch Biopartners Faces Downside Pressure Following 4.30% Decline: Clinical Trial Execution, Funding Runway, and Biotech Sentiment in Focus
Read at kalkine.ca →📈 Biotech InvestmentSep 16, 2026
Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrier
Read at Fierce Biotech →📈 Biotech InvestmentSep 16, 2026
CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’
Read at Fierce Biotech →📈 Biotech InvestmentSep 16, 2026
SBIO ETF Rallies on Clinical Trial Wins & M&A Demand
Read at ETF Trends →📈 Biotech InvestmentSep 16, 2026
Sarat Ventures Targets USD 100M to Invest in 15 to 20 Biotech Companies
Read at waya.media →📈 Biotech InvestmentSep 16, 2026